Skip to main content

1 Result(s)

within Article Remove this filter A van der Sluijs-Geling Remove this filter English Remove this filter

and

  1. No Access

    Article

    Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol

    Analysis of minimal residual disease (MRD) in childhood acute myeloid leukemia (AML) may predict for clinical outcome. MRD levels were assessed by flowcytometric immunophenoty** in 94 children with AML enrol...

    V H J van der Velden, A van der Sluijs-Geling, B E S Gibson, J G te Marvelde… in Leukemia (2010)